Legal to Sell, Illegal to Manufacture?

The Future of CBD in 2027

In a recent public discussion, we were asked whether new federal hemp rules could create a paradox: CBD products remain legal to sell, but necessary intermediate extracts produced during manufacturing might be treated as Schedule I substances.

If that were true, it would represent a serious structural problem for the industry.

The answer, however, is more nuanced than the headline suggests.

Good Question

TL;DR: Regulated remediation of THC and intermediate byproducts of cultivation and manufacturing is not a new issue. Many state-regulated cannabis markets already have remediation frameworks in place. Federal agencies will likely adopt or adapt similar policies when new hemp regulations are finalized.


Why This Question Exists

Most Americans think of government as three branches:

  • Legislative - writes laws
  • Executive - enforces laws
  • Judicial - interprets laws

In practice, there is a fourth branch: the Administrative - set enforcement policy. These agencies translate broad statutes into enforceable rules and procedures.

This system is largely invisible to the public, but administrative law is the keystone of modern federal governance. Congress sets statutory boundaries. Agencies write the detailed compliance frameworks.

 

How This Applies to Hemp

Most federal statutes do not micromanage enforcement mechanics. They outline intent and delegate implementation authority to the agencies responsible for enforcement.

Disposal or reprocessing of manufacturing byproducts (commonly referred to as “remediation”) falls squarely into that delegated space.

With new hemp regulations, congressional intent appears relatively clear:

  • Redefine hemp so only non-intoxicating products may be sold outside of dispensaries
  • Establish clearer national safety expectations for consumer products

What Congress did not specify is the operational detail of how these goals should be met.

That is normal.

In regulated industries - food, pharmaceuticals, alcohol, tobacco - agencies construct the technical compliance systems that translate legislative intent into operational standards.

In this case, remediation of intermediate material has been delegated to enforcement agencies.

What happens next will depend on:

  • The final federal enforcement framework
  • Whether the producer operates in a state with a legal cannabis system
  • Whether the state allows cross-channel transfer or remediation

 

Practical Scenarios

We do not yet know exactly how this will look in 2027, but three reasonable pathways exist.

1. Licensed Cannabis Operators (Legal States)

If a manufacturer holds a cannabis license, intermediate materials exceeding hemp THC limits may be transferred into the regulated cannabis supply chain, provided state tracking systems permit it.

Many states already have remediation policies for:

  • Over-potent batches
  • Contaminated product
  • Failed laboratory results

Those frameworks could logically absorb hemp intermediates that cross the THC threshold.

2. Dual Hemp / Cannabis Facilities

In states with integrated seed-to-sale tracking systems, some operators may be able to move material between hemp and cannabis channels lawfully.

This will depend entirely on how each state structures compliance pathways.

3. Hemp-Only Operators in Non-Legal States

This remains the area of greatest uncertainty. Without a licensed cannabis pathway, exceeding THC limits could require:

  • Destruction under state supervision
  • Disposal consistent with DEA-aligned procedures
  • Or remediation processes defined through future federal rulemaking

This is where federal administrative guidance will matter most.

 

The Real Source of Industry Anxiety

The uncertainty does not stem from remediation itself. Remediation is common in regulated cannabis markets.

The anxiety stems from:

  • Unclear federal enforcement posture
  • Historical inconsistency in agency guidance
  • The gap between congressional legalization of hemp and executive enforcement against hemp

Investors and manufacturers do not fear remediation. They fear regulatory ambiguity. The core question is not whether remediation will exist.

It is how narrowly or broadly agencies will define remediation pathways.


Structural Reality

Hemp is being repositioned as a non-intoxicating commodity, as it was always intended to be. Cannabis remains regulated as an intoxicating substance under state systems.

Any intermediate product that crosses that boundary must be reconciled within one of those two frameworks. That reconciliation process, not the statutory definition itself, is what agencies are now tasked with clarifying.

Until formal rulemaking is published, the industry remains in a holding pattern.

 

Final Perspective

Remediation is not a novel legal crisis. It is an administrative detail awaiting clarification. The market is not facing a conceptual impossibility. It is facing regulatory latency.

We will have answers when agencies issue formal guidance... or when enforcement actions produce judicial precedent.

With the Supreme Court’s recent limitation of Chevron deference, courts may play a more active role in reviewing administrative interpretation going forward.

Until more clarity emerges, prudent operators are preparing for a framework that mirrors existing state cannabis remediation models rather than assuming blanket prohibition scenarios.

Back to blog

Questions & Answers

Herbal Edge Logo

About the Author

Former regional CBD wholesaler Avery Martz built Herbal Edge to help consumers navigate an industry that rarely makes it easy. Read More →